CompletedNot Applicable

Spectral CT With Advanced CT Technology

Sweden30 participantsStarted 2021-04-19

Plain-language summary

The purpose of the study is to collect data to evaluate feasibility of the using photon-counting CT in a clinical setting.

Who can participate

Age range50 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age \>50 years * Male * Normal renal function per standardized guidelines (GFR \> 60 mL/min) * Previous CT examination at KS no more than 12 months prior to the study examination * Signed informed consent Exclusion Criteria: * Iodine contrast is contraindicated.

What they're measuring

Evaluate feasibility of the photon-counting CT in a clinical setting.

Timeframe: 1 year

Trial details

NCT IDNCT04781296

SponsorGE Healthcare

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2022-12-14

View on ClinicalTrials.gov More CT Photon-Counting trials